Diazolidinylurea is a broad-spectrum antimicrobial preservative used in cosmetics and pharmaceutical preparations. It is especially active against gram-negative bacteria and is often combined with parabens. Diazolidinylurea is the most active member of the imidazolidinyl urea group, that acts as a formaldehyde releasers. Diazolidinylurea is used in many cosmetics, skin care products, shampoos, and conditioners, as well as a wide range of products including bubble baths, baby wipes, and household detergents.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Inactive ingredient | Pain Relief Cream by ALLURE LABS INC. Approved UseTopical Analgesic
Uses: For the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains and bruises. Launch Date2017 |
| Substance Class |
Mixture
Created
by
admin
on
Edited
Mon Mar 31 21:49:51 GMT 2025
by
admin
on
Mon Mar 31 21:49:51 GMT 2025
|
| Record UNII |
H5RIZ3MPW4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB22255
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
100000088403
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
C044982
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
H5RIZ3MPW4
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
78491-02-8
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
MAJOR COMPONENT STRUCTURE/SEQUENCE | |||
|
4652
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
H5RIZ3MPW4
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
m4273
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | Merck Index | ||
|
N0000171131
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
N0000175629
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
DIAZOLIDINYL UREA
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
1310602
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | RxNorm | ||
|
C45678
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
N0000184306
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
DB14173
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY | |||
|
C80924
Created by
admin on Mon Mar 31 21:49:51 GMT 2025 , Edited by admin on Mon Mar 31 21:49:51 GMT 2025
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |